Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Recognizing resistance or susceptibility to the current standard cisplatin and paclitaxel treatment could improve therapeutic outcomes of metastatic or recurrent cervical cancer. | Prognostic and predictive factors in patients with metastatic or recurrent cervical cancer treated with platinum-based chemotherapy